The share

The shares of Inify Laboratories AB are listed on Euronext Growth Oslo since June 20th, 2022. All shares have equal rights and are freely transferable. Please follow the development of the Inify Laboratories share on Euronext Growth and view stock exchange releases at NewsWeb.
Euronext Growth
NewsWeb

Share information

Ticker code
Number of shares
Trading currency
Sector
ISIN
LEI code
INIFY
78,903,416
NOK
Health care
SE0017486103
549300306YYJ3BX3VB98

Shareholders

The shares of Inify Laboratories AB are listed on Euronext Growth Oslo under the ticker INIFY.
The list of total shares and the 20 largest shareholders is updated monthly, usually at month end. The last update was made on April 30th, 2025. The company has a total of 78,903,416 outstanding shares.
Euronext Growth

20 largest shareholders

Number of shares heldOwnership (%)Shareholder
47 410 66060,09%Gallivant S.á.r.l.
9 236 65211,71%TAURI AS
8 043 89610,19%MONSUN AS
2 600 0003,30%BRAS KAPITAL AS
1 964 7682,49%Günther-Hanssen, Sven
1 889 7042,39%Danske Bank A/S
1 382 2431,75%MP PENSJON PK
805 7031,02%Avanza Bank AB
538 8510,68%OLSEN, LARS EJNAR
425 8000,54%STAVLAND, PER
302 9860,38%SKJELBRED, RUNE
301 3040,38%Danske Bank A/S
295 0980,37%SVEEN, KRISTIAN
265 1360,34%Skandinaviska Enskilda Banken AB
174 7610,22%Nordnet Bank AB
156 4950,20%STAVLAND, WENCHE SOFIE
137 6500,17%SANDVIK, RUNE
119 1630,15%OLE KRISTIAN AS
100 0000,13%STORHAUGEN INVEST AS
87 4540,11%Swedbank AB
2 665 0923,38%Others
78 903 416100,00%Total

Primary Insider Transactions

Information about primary insider transactions can be found under Investor news.

Dividend policy

The board of Inify Laboratories AB has not adopted a dividend policy since the Company considers itself to be in a growth phase, and therefore does not foresee that it will pay dividends in the near future. In deciding whether to propose a dividend and in determining the dividend amount, the Board of Directors will take into account legal restrictions as well as capital expenditure plans, financing requirements and maintaining the appropriate strategic flexibility.